Related Experiment Videos
Approach to the patient with diffuse lung disease.
P E Krumpe1, C C Lum, C E Cross
1University of California-Davis.
The Medical Clinics of North America
|September 1, 1988
Summary
Diagnosing diffuse lung infiltrates requires considering symptom acuity, non-pulmonary factors, and exposures. Effective treatment for non-infectious lung disease often involves immunosuppression, with research focusing on fibrosis mechanisms.
Area of Science:
- Pulmonology
- Immunology
- Radiology
Background:
- Diffuse lung infiltrates present a diagnostic challenge for clinicians.
- A systematic approach is crucial for accurate diagnosis and effective management.
Purpose of the Study:
- To outline a diagnostic strategy for evaluating diffuse lung infiltrates.
- To discuss therapeutic approaches and areas of research in non-infectious diffuse lung disease.
Main Methods:
- Clinical evaluation emphasizing symptom acuity, non-pulmonary findings, and exposures.
- Radiographic and pulmonary function test interpretation to narrow differential diagnoses.
- Consideration of patient-specific factors like age and medical condition for workup direction.
Main Results:
- Diagnostic clues include symptom onset, associated conditions, environmental history, and immunosuppressive risk factors.
- Radiographic features (opacity distribution, adenopathy, lines, pneumothorax) and PFTs aid in differential diagnosis.
- Therapy for non-infectious diffuse lung disease is often unsatisfactory without a specific diagnosis, with immunosuppression used to control inflammation.
Conclusions:
- A comprehensive evaluation integrating clinical, radiographic, and functional data is essential for diagnosing diffuse lung infiltrates.
- Immunosuppressive therapy may be necessary for active inflammatory processes, but research into the molecular basis of pulmonary fibrosis is key for future treatments.